Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1736–88.

Article  Google Scholar 

Bosco E, Hsueh L, McConeghy KW, Gravenstein S, Saade E. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review. BMC Med Res Methodol. 2021;21(1):1–18.

Article  Google Scholar 

Pepine CJ, Kowey PR, Kupfer S, Kolloch RE, Benetos A, Mancia G, et al. Predictors of adverse outcome among patients with hypertension and coronary artery disease. J Am Coll Cardiol. 2006;47(3):547–51.

Article  PubMed  Google Scholar 

Kim SH, Cho YK, Kim YJ, Jung CH, Lee WJ, Park JY, et al. Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study. Cardiovasc Diabetol. 2022;21(1):81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobiasova M, Frohlich J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr Lek. 2000;46(3):152–6.

CAS  PubMed  Google Scholar 

Wu J, Zhou Q, Wei Z, Wei J, Cui M. Atherogenic index of plasma and coronary artery disease in the adult population: a meta-analysis. Front Cardiovasc Med. 2021;8:817441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, Chen S, Tian X, Wang P, Xu Q, Xia X, et al. Association between cumulative atherogenic index of plasma exposure and risk of myocardial infarction in the general population. Cardiovasc Diabetol. 2023;22(1):210.

Article  PubMed  PubMed Central  Google Scholar 

Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, Pérez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285–94.

Article  PubMed  Google Scholar 

Zheng H, Wu K, Wu W, Chen G, Chen Z, Cai Z, et al. Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study. Cardiovasc Diabetol. 2023;22(1):313.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu L, Zhou Y, Sun J, Zhu Z, Xing Z, Zhou S, et al. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2021;20(1):1–11.

Article  Google Scholar 

Hang F, Chen J, Wang Z, Zheng K, Wu Y. Association between the atherogenic index of plasma and major adverse cardiovascular events among non-diabetic hypertensive older adults. Lipids Health Dis. 2022;21(1):1–7.

Article  Google Scholar 

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group*. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.

Article  PubMed  Google Scholar 

Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011;2(1):1–12.

Ma X, Sun Y, Cheng Y, Shen H, Gao F, Qi J, et al. Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention. Lipids Health Dis. 2020;19(1):1–13.

Article  Google Scholar 

Toprak K, Kaplangoray M, Akyol S, İnanır M, Memioğlu T, Taşcanov MB et al. The non-HDL-C/HDL-C ratio is a strong and independent predictor of the no-reflow phenomenon in patients with ST-elevation myocardial infarction. Acta Cardiol. 2023;1–12.

Wang Y, Wang S, Sun S, Li F, Zhao W, Yang H, et al. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8 mmol/L. Cardiovasc Diabetol. 2023;22(1):1–10.

Google Scholar 

Liu Y, Feng X, Yang J, Zhai G, Zhang B, Guo Q, et al. The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris. BMC Endocr Disorders. 2023;23(1):187.

Article  CAS  Google Scholar 

Erdoğan A, İnan D, Genç Ö, Yıldız U, Demirtola Aİ, Çetin İ, et al. The triglyceride–glucose index might be a Better Indicator for Predicting Poor Cardiovascular Outcomes in Chronic Coronary Syndrome. J Clin Med. 2023;12(19):6201.

Article  PubMed  PubMed Central  Google Scholar 

Çelik İE, Öztürk S, Yarlıoğlu M, Barutçu O, Akgün O, Duran M, et al. The Association between Atherogenic Index of plasma and No-Reflow Phenomenon in Acute Coronary Syndrome. Anatol J Cardiol. 2023;27(12):712.

Article  PubMed  PubMed Central  Google Scholar 

Alifu J, Xiang L, Zhang W, Qi P, Chen H, Liu L, et al. Association between the atherogenic index of plasma and adverse long-term prognosis in patients diagnosed with chronic coronary syndrome. Cardiovasc Diabetol. 2023;22(1):255.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kasapkara HA, Erdoğan M. Association between atherogenic index of plasma and in-hospital mortality in patients with STEMI undergoing primary percutaneous coronary intervention. J Health Sci Med. 2023;6(1):158–64.

Google Scholar 

Özen Y, BILAL ÖZBAY M, Yakut İ, Kanal Y, Abdelmottaleb W, Nriagu B et al. Atherogenic index of plasma and triglycerideglucose index to predict more advanced coronary artery diseases in patients with the first diagnosis of acute coronary syndrome. Eur Rev Med Pharmacol Sci. 2023;27(9).

Kan Y, Sun Y, Shen H, Liu X, Liu Y, Shi D, et al. Effect of body Mass Index on the Prognostic Value of Atherogenic Index of Plasma in patients with Acute Coronary Syndrome undergoing percutaneous coronary intervention. J Clin Med. 2023;12(20):6543.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abacıoğlu ÖÖ, Yıldırım A, Koyunsever NY, Karadeniz M, Kılıç S. Relationship between atherogenic index of plasma and stent thrombosis in patients with acute coronary syndrome. Anatol J Cardiol. 2022;26(2):112.

Article  PubMed Central  Google Scholar 

Qiao-Yu S, Xiao-Teng M, Zhi-Qiang Y, Qiu-Xuan L, Yu-Fei W, Liang J, et al. Prognostic significance of multiple triglycerides-derived metabolic indices in patients with acute coronary syndrome. J Geriatric Cardiology: JGC. 2022;19(6):456.

Google Scholar 

Zheng Y, Li C, Yang J, Seery S, Qi Y, Wang W, et al. Atherogenic index of plasma for non-diabetic, coronary artery disease patients after percutaneous coronary intervention: a prospective study of the long-term outcomes in China. Cardiovasc Diabetol. 2022;21(1):1–14.

Article  Google Scholar 

Refaat H, Tantawy A, Gamal AS, Radwan H. Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention. Indian Heart J. 2021;73(1):35–43.

Article  PubMed  Google Scholar 

Süleymanoğlu M, Rencüzoğulları İ, Karabağ Y, Çağdaş M, Yesin M, Gümüşdağ A, et al. The relationship between atherogenic index of plasma and no-reflow in patients with acute ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention. Int J Cardiovasc Imaging. 2020;36:789–96.

Article  PubMed  Google Scholar 

Qin Z, Zhou K, Li Y, Cheng W, Wang Z, Wang J, et al. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19:1–11.

Article  CAS  Google Scholar 

Sadeghi M, Heshmat-Ghahdarijani K, Talaei M, Safaei A, Sarrafzadegan N, Roohafza H. The predictive value of atherogenic index of plasma in the prediction of cardiovascular events; a fifteen-year cohort study. Adv Med Sci. 2021;66(2):418–23.

Article  PubMed  Google Scholar 

Hamzeh B, Pasdar Y, Mirzaei N, Faramani RS, Najafi F, Shakiba E, et al. Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran. Lipids Health Dis. 2021;20(1):82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nansseu JRN, Ama Moor VJ, Nouaga MED, Zing-Awona B, Tchanana G, Ketcha A. Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women. Lipids Health Dis. 2016;15(1):49.

Article  PubMed  PubMed Central  Google Scholar 

Huang H, Yu X, Li L, Shi G, Li F, Xiao J, et al. Atherogenic index of plasma is related to coronary atherosclerotic disease in elderly individuals: a cross-sectional study. Lipids Health Dis. 2021;20(1):68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong L, Han Y, Deng C, Chen A. Correlation between atherogenic index of plasma and coronary artery disease in males of different ages: a retrospective study. BMC Cardiovasc Disord. 2022;22(1):440.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Khakurel G, Kayastha R, Chalise S, Karki PK. Atherogenic index of plasma in postmenopausal women. 2018.

Tagoe EA, Dwamena-Akoto E, Nsaful J, Aikins AR, Clegg-Lamptey JN, Quaye O. High atherogenic index of plasma and cardiovascular risk factors among Ghanaian breast cancer patients. Exp Biol Med (Maywood). 2020;245(18):1648–55.

Article  CAS  PubMed  Google Scholar 

Nwagha U, Ikekpeazu E, Ejezie F, Neboh E, Maduka I. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu. Nigeria Afr Health Sci. 2010;10(3).

Hegde SN. Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b for cardiovascular risk assessment–what is the right choice? APIK J Intern Med. 2020;8(2):48–50.

Article  Google Scholar 

Hoogeveen RC, Ballantyne CM. Residual cardiovascular risk at low LDL: remnants, lipoprotein (a), and inflammation. Clin Chem. 2021;67(1):143–53.

Article  PubMed  Google Scholar 

Ikezaki H, Lim E, Cupples LA, Liu C, Asztalos BF, Schaefer EJ. Small dense low-density lipoprotein cholesterol is the most atherogenic lipoprotein parameter in the prospective Framingham offspring study. J Am Heart Association. 2021;10(5):e019140.

Article  CAS  Google Scholar